drugset / Trial / NCT06321705
Safety and Efficacy of Continued CS1 Treatment of Patients With Pulmonary Arterial Hypertension
Summary
CS1-004 will be an extension of the CS1-003 Study. The primary objective of the CS1-004 study is to evaluate long-term safety and tolerability of continued treatment with CS1.
Timeline
- Start
- —
- Primary completion
- —
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | CS1 | Unknown | 480 mg | — |
| Subject | CS1 | Unknown | 960 mg | — |
| Subject | CS1 | Unknown | 1920 mg | — |